HENAN TALOPH PHARMACEUTICAL STOCK CO.,LTD |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.07 CNY | -2.31% |
|
-3.80% | -17.29% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
HENANTALOPHPHARMACEUTICALSTOCKCO., LTD is a China-based company principally engaged in the research and development, manufacture and sales of pharmaceuticals. The Company provides oral solutions, transfusion and tablets, which are applied in the treatment of cold, diabetes and virus infection. The Company's main products include Shuanghuanglian oral liquid products, double gold agents, Haberffine tablets and compound Yimu oral solutions, among others. The Company distributes its products mainly within domestic market.
Sector
Pharmaceuticals
Calendar
25/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -17.29% | 391M | |
| +37.78% | 723B | |
| +32.82% | 598B | |
| -3.51% | 364B | |
| +19.94% | 331B | |
| +5.14% | 288B | |
| +16.64% | 244B | |
| -4.13% | 208B | |
| +10.63% | 210B | |
| +9.32% | 169B |
- Stock Market
- Equities
- 600222 Stock
- News Henan Taloph Pharmaceutical Stock Co.,Ltd
- Taloph Pharmaceutical Gets Nod to Amend License of Three Products
